DE3478689D1 - Neocarzinostatin derivatives and a process for manufacturing the same - Google Patents

Neocarzinostatin derivatives and a process for manufacturing the same

Info

Publication number
DE3478689D1
DE3478689D1 DE8484305414T DE3478689T DE3478689D1 DE 3478689 D1 DE3478689 D1 DE 3478689D1 DE 8484305414 T DE8484305414 T DE 8484305414T DE 3478689 T DE3478689 T DE 3478689T DE 3478689 D1 DE3478689 D1 DE 3478689D1
Authority
DE
Germany
Prior art keywords
residue
neocarzinostatin
maleic acid
sma
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8484305414T
Other languages
German (de)
English (en)
Inventor
Hiroshi Maeda
Ryunosuke Kanamaru
Nakao Ishida
Toshihiko Yoshitake
Minoru Ueda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KAYAKU ALSO TRADING AS KAYAKU
Kuraray Co Ltd
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
KAYAKU ALSO TRADING AS KAYAKU
Kuraray Co Ltd
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KAYAKU ALSO TRADING AS KAYAKU, Kuraray Co Ltd, Yamanouchi Pharmaceutical Co Ltd filed Critical KAYAKU ALSO TRADING AS KAYAKU
Application granted granted Critical
Publication of DE3478689D1 publication Critical patent/DE3478689D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE8484305414T 1983-08-08 1984-08-08 Neocarzinostatin derivatives and a process for manufacturing the same Expired DE3478689D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58145419A JPS6075499A (ja) 1983-08-08 1983-08-08 ネオカルチノスタチン誘導体及びその製造法

Publications (1)

Publication Number Publication Date
DE3478689D1 true DE3478689D1 (en) 1989-07-20

Family

ID=15384811

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484305414T Expired DE3478689D1 (en) 1983-08-08 1984-08-08 Neocarzinostatin derivatives and a process for manufacturing the same

Country Status (6)

Country Link
US (1) US4762885A (enExample)
EP (1) EP0136792B1 (enExample)
JP (1) JPS6075499A (enExample)
AT (1) ATE44035T1 (enExample)
CA (1) CA1241640A (enExample)
DE (1) DE3478689D1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2556865B2 (ja) * 1986-09-19 1996-11-27 山之内製薬株式会社 ネオカルチノスタチン誘導体の非注射投与用組成物
US5389366A (en) * 1986-09-19 1995-02-14 Yamanouchi Pharmaceutical Co., Ltd. Neocarzinostatin derivative composition for oral administration
CA1327161C (en) * 1987-09-01 1994-02-22 Mitsugu Kobayashi Lyophilized pharmaceutical composition of neocarzinostatin derivative
US7682630B2 (en) * 2003-05-26 2010-03-23 Hiroshi Maeda Antitumor agent and process for producing the same
WO2006080171A1 (ja) 2005-01-31 2006-08-03 Effector Cell Institute, Inc. 免疫増強剤
CA2933838A1 (en) 2013-11-19 2015-05-28 Hiroshi Maeda Derivative of styrene-maleic acid copolymer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3085994A (en) * 1959-10-30 1963-04-16 Sinclair Research Inc Chain terminated copolymer of styrene and maleic anhydride of low solution viscosity
US3121043A (en) * 1960-05-11 1964-02-11 Scient Associates Inc Sustained release pharmaceutical preparation and methods for making same
US3245933A (en) * 1960-05-19 1966-04-12 Sinclair Research Inc Styrene-maleic anhydride copolymers cross-linked with aliphatic polyhydroxy compounds
JPS6017206B2 (ja) * 1977-03-24 1985-05-01 浩 前田 ネオカルチノスタチン誘導体の製造法
DE3367921D1 (en) * 1982-02-27 1987-01-15 Kuraray Co Neocarzinostatin complexes, a method for producing the same, and an antitumor agent containing said complexes as an active component

Also Published As

Publication number Publication date
JPH0133120B2 (enExample) 1989-07-11
EP0136792A2 (en) 1985-04-10
JPS6075499A (ja) 1985-04-27
ATE44035T1 (de) 1989-06-15
CA1241640A (en) 1988-09-06
EP0136792B1 (en) 1989-06-14
EP0136792A3 (en) 1985-12-18
US4762885A (en) 1988-08-09

Similar Documents

Publication Publication Date Title
Roy et al. Amphiphilic p‐tert‐butylcalix [4] arene scaffolds containing exposed carbohydrate dendrons
DE3067935D1 (en) Antitumor protein hybrid and process for the preparation thereof
AU1542788A (en) Branched acrylate copolymerisate with polymerizable double bonds and process for manufacture thereof
ATE73110T1 (de) Kieselsaeuren.
MY141603A (en) Aromatic amine compounds, their method of preparation & pharmaceutical compositions in which they are present
NZ226845A (en) 2', 3'-dideoxy-2'-fluoronucleosides; pharmaceutical compositions and processes for their preparation
NO923081L (no) Neurobeskyttende 3-piperidino-4-hydroksykromanderivater og analoger derav
DE3478689D1 (en) Neocarzinostatin derivatives and a process for manufacturing the same
DE3162817D1 (en) Immunostimulating glycoproteins extracted from klebsiella pneumoniae, process for obtaining them, their application as medicaments and compositions containing them
GB1553595A (en) Pyrrolidones and process for their manufacture
DE3067313D1 (en) Antitumor protein hybrid and process for the preparation thereof
AU4068689A (en) Iodinated polymers with dextran skeleton, processes for their preparation and their uses as contrast products
ATE141926T1 (de) Neue cobalamin-säurehydrazide und davon abgeleitete cobalamin-konjugate
DE3477005D1 (en) Neocarzinostatin derivatives and method of producing the same
ES386010A2 (es) Procedimiento de copolimerizacion de nuevos copolimeros porbloques.
NZ203185A (en) Imidazolidines and pharmaceutical compositions
CA2072250A1 (en) Flowability improving agent, a process for the production trereof and a use thereof
IE802111L (en) Polyvinylpyrrolidone-iodine
ES482138A1 (es) Procedimiento para la obtencion de 1-bencil -fenil-piperidi-nas.
AU5111490A (en) Aerosol compositions intended for the imaging, diagnosis and targeted therapy of inflammatory and tumour foci
TW217985B (en) Polythiophenecarboxylic acid derivatives used for increasing immunity
JPS56164156A (en) Preparation of polypeptide
JPS5282687A (en) Water-soluble polishing agent composition
RO88085B1 (ro) Conjugat cortisol-albumina si procedeu de obtinere a acestuia
TW329425B (en) Immunoconjugates useful for treating gastro-intestinal tumors, processes for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee